Research and Markets (http://www.researchandmarkets.com/research/47tmv6/immunosuppression) has announced the addition of the "Immunosuppression Summit 2016 - Virtual Event" webinar to their offering.
This International Immunosuppression Summit will bring together scientists to discuss the problems associated with natural and induced immunosuppression.
Who Should Attend:
This summit will interest those working in drug design and discovery, physicians and clinicians, research scientists and academics, and those who work within the industry.
Registration includes
- Access to all the talks as they are happening
- Access to the posters with the ability to ask poster presenters questions
- Ability to chat online to all delegates including speakers and chairs
- Access to all the Q and A sessions with the facility to ask questions
- Access to the delegate list in real time
- Access to all the talks for up to one week after the event.
Talks Include:
- Malignancies in the HIV-infected population
- Autoimmunity diseases and cutaneous melanoma
- Immunosuppression for kidney transplantation - the good, the bad and the ugly
- Induction of antigen specific Treg from naïve non-antigen specific CD4+CD25+FOXP3+T regulatory cells to promote specific immune tolerance.
- Stabilizing regulatory T cells for tolerance inducing immunotherapy
- Induction of Immunosupression with polyclonal ATGs: New perspectives
- Selective inhibition of interlukin-21 (IL-21) signaling blocks type 1 diabetes and chronic allograft rejection
- The therapeutical challenge of antibody mediated-rejection
- Targeting donor rather than recipient cells to prevent rejection of transplanted organs
- Neural stem cell derived beta-endorphin transplants promote innate immunity and prevent cancers in various animal models.
- Switching off allorecognition via donor organ immunodepletion using ex-vivo perfusion
- Mesenchymal Stromal Cells with Enhanced Immunosuppressive Activity
- The infection status and its influences on methadone maintenance treatment
- The art on HIV
- Adenosine-PGE2-cAMP nexus in the tumour microenvironment - self amplifying immunosuppression?
- Immunosuppression in Chronic Lymphocytic Leukemia: the key role of c-MET/HGF interaction.
For more information visit http://www.researchandmarkets.com/research/47tmv6/immunosuppression
View source version on businesswire.com: http://www.businesswire.com/news/home/20160127005529/en/